IRIS
ALONCI, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2192
EU - Europa 2158
AS - Asia 343
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4697
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2185
IE - Irlanda 744
SE - Svezia 582
CN - Cina 321
UA - Ucraina 218
DE - Germania 158
IT - Italia 155
FI - Finlandia 106
GB - Regno Unito 88
BE - Belgio 26
AT - Austria 23
PL - Polonia 20
FR - Francia 19
IR - Iran 9
CA - Canada 6
RU - Federazione Russa 6
VN - Vietnam 6
IN - India 4
NL - Olanda 4
CH - Svizzera 3
BR - Brasile 2
NO - Norvegia 2
CL - Cile 1
CZ - Repubblica Ceca 1
EU - Europa 1
GR - Grecia 1
IQ - Iraq 1
LV - Lettonia 1
MX - Messico 1
PT - Portogallo 1
SG - Singapore 1
TR - Turchia 1
Totale 4697
Salva come PNG Salva come JPEG
Città #
Dublin 744
Chandler 562
Jacksonville 450
Nyköping 298
Beijing 172
Dearborn 122
Princeton 109
Cambridge 106
Medford 106
Messina 97
Ann Arbor 90
Des Moines 90
Boardman 70
Woodbridge 46
Wilmington 28
Brussels 26
Lancaster 22
Vienna 22
Warsaw 20
Shenyang 18
San Mateo 16
Hebei 15
Jinan 15
Nanjing 14
Tianjin 13
Ashburn 10
Bremen 10
Auburn Hills 9
Rome 9
Hangzhou 8
Houston 8
Ningbo 8
Strasbourg 7
Zhengzhou 7
Ardabil 6
Augusta 6
Dong Ket 6
Lanzhou 6
Falls Church 5
Haikou 5
Monmouth Junction 5
Seattle 5
Taiyuan 5
Changsha 4
Cosenza 4
Fuzhou 4
Latina 4
Los Angeles 4
Norwalk 4
Ottawa 4
Chapel Hill 3
Guangzhou 3
Jiaxing 3
Lausanne 3
Leawood 3
Redwood City 3
Saint Petersburg 3
Civitanova Marche 2
Hefei 2
Helsinki 2
Kunming 2
Milan 2
Modica 2
Montréal 2
Oslo 2
Riva 2
Baotou 1
Berkeley 1
Boston 1
Chaoyang 1
Chongqing 1
Clearwater 1
Dongguan 1
Evanston 1
Florence 1
Fremont 1
Gragnano 1
Hanover 1
Hongtong 1
Lisbon 1
Londrina 1
Manchester 1
Mascalucia 1
Mexico City 1
Mountain View 1
New York 1
Noto 1
Rivarolo Canavese 1
Saint Louis 1
Taizhou 1
Yuanping 1
Totale 3488
Salva come PNG Salva come JPEG
Nome #
Effect of therapeutic plasma exchange on plasma levels of oxidative biomarkers in a patient with thrombotic thrombocytopenic purpura 100
The cancer stem cell hypothesis: a guide to potential molecular targets. 87
Diagnostic utility of Sudoscan for detecting Bortezomib-induced painful neuropathy 87
L'ipersplenismo: attualità e prospettive future 76
Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies 72
Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitors 68
MDR-1 gene polymorphisms G2677T and C3435T in a case of Hodgkin's variant of Richter's syndrome 68
Absence of the V617F JAK2 Mutation in the Lymphoid Compartment in a Patient with Essential Thrombocythemia and B-Chronic Lymphocytic Leukemia and in Two Relatives with Lymphoproliferative Disorders 67
E rosette formation in B cell chronic lymphocytic leukemia. 66
Circulating levels of intercellular adhesion Molecule-1 (ICAM-1) and soluble Interleukin 2 receptors(IL-2R) in patients with B cell Chronic Lynphocityc Leukemia 63
Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma and breast cancer. 63
Evaluation of Interleukin-17 serum levels in patients with chronic myeloproliferative diseases. 61
Patients with bisphosphonate-associated osteonecrosis of the jaw have unmodified levels of soluble vascular endothelial growth factor receptor 1. 61
Assenza della mutazione JAK2 V617F nel compartimento linfoide di un paziente affetto da trombocitemia essenziale e leucemia linfatica cronica a cellule B ed in due parenti affetti da disordini linfoproliferativi 60
Angiogenesis in patients with biphosphonate-associated osteonecrosis of the jaw 59
Bisphosphonates induce apoptosis of circulating endothelial cells in multiple myeloma patients and in subjects with bisphosphonate-induced osteonecrosis of the jaws 58
Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential thrombocythemia and B-chronic lymphocytic leukemia and n two relatives with lymphoproliferative disorders 57
Elevated srum concentration of angiopoietin-2 in patients with multiple myeloma: correlation with markers of disease 55
Angiogenesis in patients with bisphosphonate-associated osteonecrosis of the jaw. 55
Immunohistochemical evaluation of sarcoglycans and integrins in gingival epithelium of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw. 55
Serum levels of soluble ICAM-1 in patients with malignant lymphoma in association with treatment response. 55
ABERRANT EXPRESSION OF CANCER TESTIS ANTIGENS IN HEMATOLOGIC MALIGNANCIES 54
Carbonyl groups serum levels are associated with CD38 expression in patients with B chronic lymphocytic leucemia. 54
Immunohistochemical evaluation of sarcoglycans and integrin in gingival epithelium of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw 53
Cardiac involvement in patients with hematologic malignancies. 53
Beta 2 microglobulina ed emopatie maligne 53
Lipid profile in hematologic neoplasms 52
Serum levels of interleukin-16 in lymphoid malignancies. 52
Circulating levels of intercellular adhesion molecule-1 (ICAM-1) and soluble interleukin 2 receptors (IL-2R) in patients with B cell chronic lymphocytic leukaemia. 52
Increased levels of the soluble adhesion molecule E-selectin in patients with chronic myeloproliferative disorders and thromboembolic complications 52
Severe dermatologic adverse reactions after exposure to lenalidomide in multiple myeloma patients with a positive HLA-DRB1*1501 and HLA-DQB1*0602. 51
Evaluation des sous-populations lymphocytaires chez des travailleurs exposés a basse dose du benzene. Données préliminaires”. 50
SOLUBLE ANGIOGENIC FACTORS: IMPLICATIONS FOR CHRONIC MYELOPROLIFERATIVE DISORDERS 49
MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis. 49
Circulating endothelial progenitor cells and angiogenic serum factors in patients with chronic myeloproliferative diseases 48
Efficacia di Nilotinib in un giovane paziente affetto da LMC ad alto rischio Sokal in fallimento dopo inatinib ad alte dosi 48
MARKERS OF ENDOTHELIAL AND PLATELET STATUS IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND PLYCYTHEMIA VERA 47
Cold pressor test raises serum concentrations of ICAM-1, VCAM- 1, and E-selectin in normotensive and hypertensive patients 47
Increase in serum protein carbonyl groups is associated with more advanced stage of disease in multiple myeloma patients. 47
Serum levels of Interleukin-16 in a multiple myeloma patient with cutaneous involvement 46
JAK2 V617F-positive latent essential thrombocythemia and splanchnic vein thrombosis: the role of bone marrow biopsy for the diagnosis of myeloproliferative disease. 46
Evaluation of circulating endothelial cells, VEGF and VEGFR2 serum levels in patients with chronic myeloproliferative diseases. 46
Decreased plasma levels of IL-33 could contribute to the altered function of Th2 Iymphocytes in patients with poIycythemia vera and essential thrombocythemia. 46
MULTIDRUG RESISTANCE-1 GENE POLYMORPHISM ASSOCIATED WITH THE NEW MARKER OF DISEASE PROGRESSION AND POOR PROGNOSIS IN b-CELL CHRONIC LIMPHATIC LEUKEMIA 45
Increase of IL-17, IL-22 and IL-23 serum levels induced by immunoglobulin infusion for Parvovirus-B associated Pure Red Cell Aplasia in a renal transplant recipient. 45
Endothelial progenitor cells: pathogenetic role and therapeutic perspectives 44
Possible role of Interleuki-31/33 Axis in Imatinib Mesylate-Associated Skin Toxicity 44
EFFECTIVE THERAPY OF APLASTIC-ANEMIA POSTHEPATITIS WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN 43
Monocytes and lymphocytes as active participants in the pathogenesis of experimental shock 43
Serum levels of 2',5 oligoadenylate synthetase during interferon therapy in patients with B-cell chronic lymphocytic leukemia 43
Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review). 43
Patients with bisphosphonates-associated osteonecrosis of the jaw have reduced circulating endothelial cells 43
METHYMAZOLE-INDUCED AGRANULOCYTOSIS AND QUICK RECOVERY WITH G-CSF: CARE REPORT 42
Correlazione del polimorfismo genico di MDR-1 con i nuovi marcatori prognostici in pazienti affetti da Leucemia Linfatica Cronica a cellule B. 42
Interleukin 22 is increased and correlated with CD38 expression in patients with B-chronic lymphocytic leukemia 42
Prognostic significance of immunophenotype in chronic lymphocytic leukaemia 41
Prognostic value of serum thymidine kinase and beta 2 microglobulin in subjects affected by multiple myeloma 41
JAK2-Positive Latent Essential Thrombocythemia and Splanchnic Vein Thrombosis: The Role of Bone Marrow Biopsy for the Diagnosis of Myeloproliferative Disease. 40
Association of osteonecrosis of the jaws and POEMS syndrome in a patient assuming rituximab. 40
POLYRADICOLONEUROPATHY AS A FORM OF RELAPSE IN A PATIENT WITH ACUTE MEGACARYOCYTIC LEUKAEMIA 39
SERUM LEVELS OF 2', 5 OLIGOADENYLATE SYNTHETASE DURING INTERFERON THERAPY IN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC- LEUKEMIA 39
Epigenetic therapy in myelodysplastic syndromes. 39
Stevens-Johnson syndrome after lenalidomide therapy for multiple myeloma: a case report and a review of treatment options. 39
Increased levels of the soluble adhesion molecule E-selectin in patients with chronic myeloproliferative disorders and thromboembolic complications 38
Serum levels of soluble ICAM-1 in patients with malignant lymphoma in association with treatment response 38
Myeloproliferative Disease: Markers of Endothelial and Platelet Status in Patients with Essential Thrombocythemia and Polycythemia Vera. 38
Involvement of T2677T multidrug resistance gene polymorphism in Interleukin 22 plasma concentration in B-chronic lymphocytic leukemia patients. 38
Avascular Necrosis of Bone in Leukemia and Osteonecrosis of Jaw by Bisphosphonates 38
Standardisation of minimal residual disease in multiple myeloma 37
Serum levels of Interleukin-16 as an important prognostic factor in multiple Myeloma patient with cutaneous involvement 36
Serum levels of interleukin-16 in a multiple myeloma patient with cutaneous involvement. 36
Changes in advanced oxidation protein products, advanced glycation end products, and s-nitrosylated proteins, in patients affected by polycythemia vera and essential thrombocythemia 36
SERUM LEVELS OF CD8-ANTIGEN AND SOLUBLE INTERLEUKIN-2 RECEPTORS IN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA 35
Reduced serum levels of interleukin 17 in patients with osteonecrosis of the jaw and in multiple myeloma subjects after bisphosphonates administration 35
Serum levels of CD8 antigen and soluble interleukin 2 receptors in patients with B cell chronic lymphocytic leukemia. 35
Soluble CD138 serum levels are not associated with other poor prognostic markers in patients with B-chronic lymphocytic leukaemia. 35
Reduction in IL-33 Plasma Levels Might Be Involved in T Cell Dysregulation in Chronic Lymphocytic Leukemia. 35
E-ROSETTE FORMATION IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA 34
Fludarabine based treatment caused improvement of anemia in a patient with T-cell LGL leukemia despite evidence of the persistence of the abnormal T-cell clone. 34
Imatinib mesylate treatment in a patient with chemoresistant Ph+ acute myeloid leukemia: possible role of Wilms' tumor gene 1. 34
Intracellular and serum levels of aldolase activity in B chronic lymphocytic leukemia. 33
Significance of serum interleukin-16 levels in patients with B-cell chronic lymphocytic leukemia 31
INTRACELLULAR AND SERUM LEVELS OF ALDOLASE ACTIVITY IN B- CHRONIC LYMPHOCYTIC-LEUKEMIA 31
Soluble angiogenic factors: Implications for chronic myeloproliferative disorders 31
null 31
Screening dei deficit di G-6-PD in un campione di una popolazione scolastica 31
Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma. 31
Differential levels of soluble angiopèoietin-2 and Tie-2 in patients with haematological malignancies 30
Differential levels of soluble angiopoietin-2 and Tie-2 in patients with haematological malignancies. 30
MiRNome expression is deregulated in the peripheral lymphoid compartment of multiple myeloma 30
Imatinib mesylate therapy induces reduction in neutrophil gelatinase-associated lipocalin serum levels and increase in leptin concentrations in chronic myeloid leukemia patients in molecular remission. 30
Increased serum levels of neutrophil gelatinase-associated lipocalin in patients with essential thrombocythemia and polycythemia vera. 29
Evaluation of circulating endothelial progenitor cells in patients with bisphosphonate-associated osteonecrosis of the jaw 29
null 28
Levels of soluble angiogenin in chronic myeloid malignancies: clinical implications 28
Leukocyte integrin very late antigen-4/vascular cell adhesion molecule-1 adhesion pathway in splanchnic artery occlusion shock 28
Soluble CD138 serum levels are not associated with other poor prognostic markers in patients with B-chronic lymphocytic leukaemia. 28
Exacerbation of chronic idiopathic thrombocytopenic purpura following reactivation of an occult hepatitis B. 28
null 28
Increased serum levels of interleukin-31 could modulate inflammatory processes in multiple sclerosis 28
Totale 4530
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9360
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9360
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018137 0000 00 00 2031104
2018/2019189 210717 9232 102 4238
2019/2020795 10241436 14116 12283 101221414
2020/2021706 95312547 2992 841 41858159
2021/2022641 5571420 188 4026 138998253
2022/20232004 16416882174 165199 19114 919000
Totale 4750